{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T06:06:53Z","timestamp":1649138813766},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T00:00:00Z","timestamp":1569369600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T00:00:00Z","timestamp":1569369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s00347-019-00976-8","type":"journal-article","created":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T17:03:40Z","timestamp":1569431020000},"page":"571-574","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exazerbation einer okul\u00e4ren Myasthenia gravis"],"prefix":"10.1007","volume":"117","author":[{"given":"Loic","family":"Sermeus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annekatrin","family":"Rickmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosemarie","family":"Schlosser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Szurman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Januschowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,25]]},"reference":[{"issue":"1","key":"976_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1055\/s-2003-812457","volume":"72","author":"C Schneider-Gold","year":"2004","unstructured":"Schneider-Gold\u00a0C, Hartung\u00a0HP (2004) Myasthenia gravis: pathology, diagnosis and treatment. Fortschr Neurol Psychiatr 72(1):45\u201356","journal-title":"Fortschr Neurol Psychiatr"},{"key":"976_CR2","unstructured":"Fachinformation Bevacizumab. \nhttps:\/\/www.roche.de\/dok\/Avastin-reg-Infusionsloesungskonzentrat-fachinfo-0-na-attach.pdf\n\n. Zugegriffen: 26. Mai 2018"},{"key":"976_CR3","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1056\/NEJMc052954","volume":"354","author":"P Glusker","year":"2006","unstructured":"Glusker\u00a0P, Recht\u00a0L, Lane\u00a0B (2006) Reversible posterior leukoencephalopathy syndrome and bevacizumab. N\u00a0Engl J Med 354:980\u2013982","journal-title":"N Engl J Med"},{"key":"976_CR4","first-page":"69","volume":"7","author":"T Hager","year":"2014","unstructured":"Hager\u00a0T, Seitz\u00a0B (2014) Ocular side effects of biological agents in oncology: what should the clinician be aware of? Onco Targets Ther 7:69\u201377","journal-title":"Onco Targets Ther"},{"issue":"21","key":"976_CR5","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/jnci\/djr373","volume":"103","author":"O-PR Hamnvik","year":"2011","unstructured":"Hamnvik\u00a0O\u2011PR, Larsen\u00a0PR, Marqusee\u00a0E (2011) Thyroid Dysfunction from Antineoplastic Agents. J\u00a0Natl Cancer Inst 103(21):1572\u20131587","journal-title":"J Natl Cancer Inst"},{"issue":"22","key":"976_CR6","doi-asserted-by":"publisher","first-page":"19305","DOI":"10.18632\/oncotarget.4191","volume":"6","author":"R Berardi","year":"2015","unstructured":"Berardi\u00a0R, Brunelli\u00a0A, Pagliaretta\u00a0S, Paolucci\u00a0V, Conti\u00a0A, Goteri\u00a0G et\u00a0al (2015) Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy. Oncotarget 6(22):19305\u201319315","journal-title":"Oncotarget"},{"issue":"4","key":"976_CR7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/00002371-200207000-00009","volume":"25","author":"PG Fraenkel","year":"2002","unstructured":"Fraenkel\u00a0PG, Rutkove\u00a0SB, Matheson\u00a0JK et al (2002) Induction of myasthenia gravis, myositis, and insulin-dependent diabetes mellitus by high-dose interleukin\u20112 in a\u00a0patient with renal cell cancer. J\u00a0Immunother 25(4):373\u2013378","journal-title":"J Immunother"},{"key":"976_CR8","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1159\/000112905","volume":"38","author":"I Bora","year":"1997","unstructured":"Bora\u00a0I, Karli\u00a0N, Bakar\u00a0M, Zarifo\u011flu\u00a0M, Turan\u00a0F, O\u011ful\u00a0E (1997) Myasthenia gravis following IFN-alpha-2a treatment. Eur Neurol 38:68","journal-title":"Eur Neurol"},{"key":"976_CR9","first-page":"415","volume":"22","author":"EK Matthews","year":"1964","unstructured":"Matthews\u00a0EK, Quilliam\u00a0JP (1964) Effects of central depressant drugs upon acetylcholine release. Br J Pharmacol 22:415\u2013440","journal-title":"Br J Pharmacol"},{"key":"976_CR10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1476-5381.1971.tb09939.x","volume":"41","author":"GDS Hirst","year":"1971","unstructured":"Hirst\u00a0GDS, Wood\u00a0DR (1971) On the neuromuscular paralysis produced by procaine. Br J Pharmacol 41:94\u2013104","journal-title":"Br J Pharmacol"},{"issue":"4","key":"976_CR11","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1080\/20009666.2018.1487245","volume":"8","author":"N Hussain","year":"2018","unstructured":"Hussain\u00a0N, Hussain\u00a0F, Haque\u00a0D, Chittivelu\u00a0S (2018) A diagnosis of late-onset Myasthenia gravis unmasked by topical antibiotics. J\u00a0Community Hosp Intern Med Perspect 8(4):230\u2013232","journal-title":"J Community Hosp Intern Med Perspect"},{"issue":"5","key":"976_CR12","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/mus.880200501","volume":"20","author":"SL Khella","year":"1997","unstructured":"Khella\u00a0SL, Kozart\u00a0D (1997) Unmasking and exacerbation of\u00a0myasthenia\u00a0gravis by ophthalmic solutions: betoxolol, tobramycin, and dexamethasone. A case report. Muscle Nerve 20(5):631","journal-title":"Muscle Nerve"},{"issue":"2","key":"976_CR13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/ana.410170222","volume":"17","author":"A Verkijk","year":"1985","unstructured":"Verkijk\u00a0A (1985) Worsening of myasthenia gravis with timolol maleate eyedrops. Ann Neurol 17(2):211\u2013212","journal-title":"Ann Neurol"},{"issue":"2","key":"976_CR14","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/0002-9394(87)90366-7","volume":"98","author":"JR Coppeto","year":"1984","unstructured":"Coppeto\u00a0JR (1984) Timolol-associated myasthenia gravis. Am J Ophthalmol 98(2):244\u2013245","journal-title":"Am J Ophthalmol"},{"key":"976_CR15","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1136\/bmj.282.6273.1359","volume":"282","author":"WD Alexander","year":"1981","unstructured":"Alexander\u00a0WD (1981) Systemic effects with eye drops. Br Med\u00a0J 282:1359","journal-title":"Br Med J"},{"issue":"5","key":"976_CR16","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3109\/15563659509013755","volume":"33","author":"A Manoguerra","year":"1995","unstructured":"Manoguerra\u00a0A, Whitney\u00a0C, Clark\u00a0RF, Anderson\u00a0B, Turchen\u00a0S (1995) Cholinergic Toxicity Resulting from Ocular Instillation of Echothiophate Iodide Eye Drops. J\u00a0Toxicol Clin Toxicol 33(5):463\u2013465","journal-title":"J Toxicol Clin Toxicol"},{"issue":"7","key":"976_CR17","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/S0196-0644(84)80522-3","volume":"13","author":"SL Adams","year":"1984","unstructured":"Adams\u00a0SL, Mathews\u00a0J, Grammer\u00a0LC (1984) Drugs that may exacerbate myasthenia gravis. Ann Emerg Med 13(7):532\u2013538","journal-title":"Ann Emerg Med"},{"issue":"3","key":"976_CR18","first-page":"210","volume":"12","author":"D Meyer","year":"1992","unstructured":"Meyer\u00a0D, Hamilton\u00a0RC, Gimbel\u00a0HV (1992) Myasthenia gravis-like syndrome induced by topical ophthalmic preparations. A case report. J\u00a0Clin Neuroophthalmol 12(3):210\u2013212","journal-title":"J Clin Neuroophthalmol"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-019-00976-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-019-00976-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-019-00976-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T02:18:04Z","timestamp":1600913884000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-019-00976-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,25]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["976"],"URL":"https:\/\/doi.org\/10.1007\/s00347-019-00976-8","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,25]]},"assertion":[{"value":"25 September 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"L.\u00a0Sermeus, A.\u00a0Rickmann, R.\u00a0Schlosser, P.\u00a0Szurman und K.\u00a0Januschowski geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}